immune tolerance: from gene expression to drug discovery therapeutic immunology group (prof. h....
Post on 21-Dec-2015
218 views
TRANSCRIPT
![Page 1: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/1.jpg)
Immune Tolerance: from Gene Expression to Drug Discovery
Therapeutic Immunology Group
(Prof. H. Waldmann)
Therapeutic Antibody Centre
(Prof. G. Hale)
![Page 2: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/2.jpg)
Immune Tolerance and Therapy
• Therapy to reverse breakdown of self tolerance in autoimmune diseases
• Tolerance induction rather than non-specific immunosuppression to avoid rejection of transplanted organs
• Reversal of acquired tolerance to tumour antigens and latent viral infections
![Page 3: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/3.jpg)
Why Start from Gene Expression?What are the approaches to find new therapeutics:
Random screening of chemical libraries in a “surrogate assay” (eg. suppression of antigen specific proliferation in vitro).
Look for monoclonal antibodies that modulate a function (eg. same assay).
Targeted chemical design/antibodies against specific protein structures.
But:
How to identify the most relevant/specific target proteins on possibly rare cells? Ideally we want targets expressed ONLY on target cells to avoid potential toxicity against other tissues.
An answer:
Look for genes that are specifically expressed in the functional cell type of interest – in our example, Th1 but NOT T regulatory (Treg) cells.
![Page 4: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/4.jpg)
Methods for Analysing Gene ExpressionAnalysis of known genes (RT-PCR/Antibodies/Protein Gels):There are >1000 interesting “immunological” genes and probably many more important but unidentified genes. How to choose?
Differential Display and Gene Cloning:Clones genes over-expressed in one cell compared to one other, but these may be shared with other cells and you don’t know what you are working with until you have it cloned and sequenced. How to choose?
Gene Chips/ArraysCan identify patterns of expression from many (10,000+) genes and multiple samples. Genes must already have been cloned (<1/3 of genome?), it is quick, but not very sensitive (or reliable?), and currently expensive.
SAGE (Serial Analysis of Gene Expression)Can identify almost the entire pattern of gene expression (the “transcriptome”) with no a priori knowledge of the gene sequences. Multiple samples are directly comparable as a database. Sensitivity depends on the number of tags sequenced: this can be labour intensive.
![Page 5: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/5.jpg)
![Page 6: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/6.jpg)
CD4+ T cell clones/lines against DBY-Ek male antigen
Clone Source Polarised in Type Cytokines
R2.2 A1(M)xRAG-1-/- IL-2 Th1 IFN-(graft primed)
R2.4 A1(M)xRAG-1-/- IL-4 Th2 IL-4, IL-10(graft primed)
Tr1D1 A1(M)xRAG-1-/- IL-10 Tr1/Treg IL-10 (IL-4)(naïve) (CD3 cloned)
A1MP A1(M) naïve Anti-CTLA4 Treg IL-10 (IL-4)
DBY-Ek peptide
SKA A1(M) + male DBY-Ek peptide Tskin/Treg IL-10line skin graft CD4+
sorted IELs
![Page 7: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/7.jpg)
![Page 8: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/8.jpg)
AE = Nla-III
TE = BsmF1
SAGE details
![Page 9: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/9.jpg)
![Page 10: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/10.jpg)
Automated DNA Sequencing Machine
![Page 11: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/11.jpg)
![Page 12: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/12.jpg)
Analysis of SAGE data
• Use SAGEv3.01 software (Velculescu et al) to extract numbers of tags from raw sequence files.
• Use Access to link tags to known genes, Unigene clusters, and ESTs (from NCBI “reliable tag” list).
• Use Excel to manipulate data tables and calculate statistics (custom written function for Beysian stats).
• Use custom written cluster analysis and presentation program (running on Acorn RISC-PC).
![Page 13: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/13.jpg)
DC cluster
T cell clone cluster
Spleen CD4 cell cluster
![Page 14: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/14.jpg)
Clustered Expression Chart
of approx. 300 known genes (CD antigens, cytokines
and receptors)
![Page 15: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/15.jpg)
A close up of a Tregcluster of known genes
![Page 16: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/16.jpg)
![Page 17: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/17.jpg)
![Page 18: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/18.jpg)
![Page 19: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/19.jpg)
![Page 20: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/20.jpg)
Real Time PCR Machine
![Page 21: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/21.jpg)
HPRT
HPRT
TM4
TM4
Th1Treg
Th1 Treg
![Page 22: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/22.jpg)
14.8** 624** 32.6** 2.8* 0.14 0.5 3.4* 0.6 9.9 1.1 0.7 0.3
1.E+00
1.E+01
1.E+02
1.E+03
1.E+04
1.E+05
1.E+06
RST RST RST RST RST RST RST RST RST RST RST RSTN TGFb2 ENK GM2A GITR Cyp11a CysF IL1R2 GRZMa LEF1 Ly116 RNTS CD3
Norm
aliz
ed m
RNA
expr
essi
on
Ratio of tolerant to rejecting skin graft expression
Quantitative RT-PCR from rejecting, syngeneic and tolerant skin grafts
![Page 23: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/23.jpg)
![Page 24: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/24.jpg)
![Page 25: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/25.jpg)
Fluorescence Activated Cell Scanner
![Page 26: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/26.jpg)
Th1Th2
Tr1D1A1MPTskin
PermeabilizedLive cells (7AAD neg)
Peptideinhibition
CD25-
CD4+CD25+
Chandra/Ly116 ->
Chandra/Ly116 ->
Chandra/Ly116 ->
![Page 27: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/27.jpg)
CD103 ->CD103 ->
CD103 -> CD103 ->
CD4 -> Chandra/Ly116 ->
CD
103
->
CD
25 -
>
Th1 (R2.2) Th2 (R2.4)
Treg(Tr1D1) Tskin(SkA)
![Page 28: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/28.jpg)
The Therapeutic Antibody Centre
![Page 29: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/29.jpg)
Humanized monoclonal antibodies against cell surface moleculesexpressed by effector but not regulatory T cells
![Page 30: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/30.jpg)
MonoclonalAntibodyProductionBioreactorSchematic
![Page 31: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/31.jpg)
Hollow Fibre Bioreactor for Antibody Production
![Page 32: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/32.jpg)
Therapeutic antibody purification
![Page 33: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/33.jpg)
Clinical Trials of Therapeutic Antibody
![Page 34: Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)](https://reader030.vdocuments.mx/reader030/viewer/2022032704/56649d5f5503460f94a3f1f7/html5/thumbnails/34.jpg)
For more information see the TIG Web site:
www.molbiol.ox.ac.uk/pathology/tig/
Or go to the Pathology Web site:
www.path.ox.ac.uk
And click on “Herman Waldmann”